H&H Pharmaceuticals, LLC v. Chattem Chemicals, Inc., et al.

District Court, D. Nevada·Decided July 30, 2026·No. 2:16-cv-02148·Unknown

Opinion

DISTRICT OF NEVADA H&H Pharmaceuticals, LLC, Case No. 2:16-cv-02148-CDS-EJY

Plaintiff Order Granting in Part the Defendants’ Motion for Attorney’s Fees v.

Chattem Chemicals, Inc., et al., [ECF No. 195]

Defendants

On August 29, 2025, the court entered an order finding that H&H Pharmaceuticals, LLC’s first amended complaint failed to sufficiently allege a Nevada Uniform Trade Secrets Act claim and that its second amended complaint was futile. Order, ECF No. 192. Accordingly, the case was dismissed with prejudice, and judgment was entered in favor of Chattem Chemicals, Inc., and Sun Pharmaceuticals Industries, Inc. Id.; J., ECF No. 193. Chattem Chemicals and Sun Pharmaceutical Industries now seek attorney’s fees in the amount of $407,691.50 pursuant to Federal Rules of Civil Procedure 54(d)(2), Local Rule 54-14, and the 2007 Settlement Agreement. Mot., ECF No. 195. The defendants also seek $25,202.48 in nontaxable costs. Id. at 5. This motion is fully briefed. Opp’n, ECF No. 201; Reply, ECF No. 202. Because I find that the defendants are the prevailing parties, I grant in part their motion for attorney’s fees. I. Background1 A. Procedural history On December 28, 2022, the court entered an order finding that the defendants prevailed on summary judgment. Order, ECF No. 121; J., ECF No. 122. On January 17, 2023, H&H appealed. Notice, ECF No. 125.

1 Given the length and history of this case, the court only includes background information necessary in rendering its decision on the defendants’ motion for attorney’s fees. The court incorporates by reference the background section in its prior order. See ECF No. 192. On January 11, 2023, the defendants moved for attorney’s fees. Mot. for attorney’s fees, ECF No. 124. The court entered an order granting in part and denying in part the defendants’ motion for attorney’s fees and costs. August 2023 order, ECF No. 132. On September 11, 2023, H&H appealed this order to the Ninth Circuit. Sep. 2023 notice of appeal, ECF No. 133. On April 23, 2024, the Ninth Circuit issued a memorandum affirming in part and vacating in part the district court’s judgment with respect to H&H’s tort and restitution causes of action and remanded to the district court to determine, in the first instance, whether H&H adequately pled a Nevada Uniform Trade Secrets Act (NUTSA) claim in its amended complaint in light of H&H’s allegation that its conversion methods are “trade secrets, as defined in the Nevada Uniform Trade Secrets Act,” and if not, whether H&H should be granted leave to replead such a claim. See H&H Pharms., LLC v. Chattem Chemicals, Inc. (H&H I), 2024 WL 1734134, at *2 (9th Cir. Apr. 23, 2024). The Ninth Circuit agreed with the district court that H&H failed to present a triable issue of fact on the required element of damage to withstand summary judgment on its standalone contract claims against Chattem. Id. at *2. So the Ninth Circuit affirmed the district court’s entry of summary judgment on those claims. Id.2 The Ninth Circuit also ordered that “[e]ach party shall bear its costs on appeal.” Id. at *3 (emphasis added). On October 10, 2024, the Ninth Circuit issued a memorandum explaining that because of its decision in H&H I, the defendants are no longer a prevailing party under the settlement agreement. H&H Pharms., LLC v. Chattem Chemicals, Inc. (H&H II), 2024 WL 4523807, at *2 (9th Cir. Oct. 18, 2024) (citing Hopkins v. City of Sierra Vista, 931 F.2d 524, 529 (9th Cir. 1991) (“Because we reverse and remand for further proceedings on the merits, there is no prevailing party and we must also reverse the district court’s award of attorneys’ fees.”); Spencer v. Klementi, 466 P.3d 1241, 1249 (Nev. 2020) (“Because [respondents] are no longer prevailing parties on [appellant’s] defamation claim, we vacate the awards of attorney fees in their favor.”). The Ninth Circuit 2 The Ninth Circuit also ordered that on remand, the district court must consider allegations of Chattem’s contractual breach when determining whether H&H has already adequately pled a statutory UTSA claim, and if not, whether H&H should be granted leave to replead such a claim. Id. at *3. further held that this is so even though it reversed only in part. Id. (citing Long v. Coast Resorts, Inc., 267 F.3d 918, 925 (9th Cir. 2001)). The Ninth Circuit rejected the defendants’ argument that they were still entitled to their attorney’s fees and costs. Id. at *2. The Ninth Circuit explained that the “suit” contemplated by the settlement agreement encompasses not just the contractual claims, but also any allegation of a misappropriation of H&H’s trade secrets (which were vacated and remanded). Id. But, the Ninth Circuit explains that on remand, the defendants may end up as the prevailing party; however, as of the date the Ninth Circuit entered its order, the defendants are no longer the prevailing party. Id. So the Ninth Circuit held that each party shall bear their costs on appeal. Id. at *2 n.2. As a result, the court’s prior order granting attorney’s fees (ECF No. 132) was vacated. See ECF No. 168. After the remand, the court held a status conference and instructed H&H to file a motion for leave to amend in accordance with Rule 15 and the applicable local rules. Mins., ECF No. 152. In compliance with the court’s instructions, H&H filed a motion to amend its amended complaint (ECF No. 157) on July 29, 2024, the court initially granted H&H’s motion (ECF No. 158), but sua sponte reconsidered its decision (ECF No. 174). United States Magistrate Judge Elayna J. Youchah issued an amended report and recommendation (R&R) on February 10, 2025, recommending that the plaintiff’s motion for leave to amend be denied.3 I entered an order adopting the amended R&R. ECF No. 192. Therein, I agreed with Judge Youchah’s findings that H&H’s first amended complaint (FAC) failed to sufficiently allege a NUTSA claim and that its second amended complaint (SAC) was futile. Id. The court

Free access — add to your briefcase to read the full text and ask questions with AI

H&H Pharmaceuticals, LLC v. Chattem Chemicals, Inc., et al., (D. Nev. 2026).

H&H Pharmaceuticals, LLC v. Chattem Chemicals, Inc., et al. (H&H Pharmaceuticals, LLC v. Chattem Chemicals, Inc., et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related